Phase 1 Randomized, Controlled, Double-blind Study to Compare the Safety and Effectiveness of Hepatitis B Vaccines in Individuals With Renal Impairment, Diabetes Mellitus or Age Greater Than 40 Years

Trial Profile

Phase 1 Randomized, Controlled, Double-blind Study to Compare the Safety and Effectiveness of Hepatitis B Vaccines in Individuals With Renal Impairment, Diabetes Mellitus or Age Greater Than 40 Years

Recruiting
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Hepatitis B vaccine (Primary) ; ADVAX; Alum
  • Indications Hepatitis B
  • Focus Adverse reactions
  • Sponsors Vaxine
  • Most Recent Events

    • 15 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 15 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 08 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top